mutations

Documents about mutations

• Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.#829483ClinicalTrials.gov
• Outcome of Different Pathogenic Mutations in Hypertrophic Cardiomyopathy#825174ClinicalTrials.gov
• Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC#895085ClinicalTrials.gov
• BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension#866403ClinicalTrials.gov
• MS Detection of Somatic Mutations in Hematological Malignancies#879488ClinicalTrials.gov
• Classical Trigeminal Neuralgia and Sodium Channel Mutations#1282967ClinicalTrials.gov
• Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations#1306776ClinicalTrials.gov
• A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations#841227ClinicalTrials.gov
• A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1.#1189099Lund University Publications
• Heterozygous germline <i>MSH3</i> mutations, and probably <i>MLH3</i> mutations, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk#475780Europe PMC
• Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress#877437ClinicalTrials.gov
• U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutations#485094Europe PMC
• Mutations prevalent in fusion protein signal peptides from African RSV strains#477919WIReDSpace
• Safety and Tolerability of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations#915959ClinicalTrials.gov
• Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability.#1088667ClinicalTrials.gov
• Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression#1139953ClinicalTrials.gov
• Caractérisation phénotypique des mutations de P53 dans le carcinome hépatocellulaire#1537789HAL (France)
• The Influence Of Job Mutations And Position Promotions On Employees' Work Spirit At State Savings Bank KCPS Meulaboh#1002673Economic: Journal Economic and Business
• Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms#1071851ClinicalTrials.gov
• AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study#1126371ClinicalTrials.gov
• AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations#859377ClinicalTrials.gov
• Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA#1398271ClinicalTrials.gov
• A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations#916667ClinicalTrials.gov
• Quantum Tunneling Was Behind Mutations... Elucidating DNA Tautomerization#383284Zenodo (CERN)
• Transition(s) et mutations : comment penser les transformations alimentaires ? Compte rendu de Florence Strigler, Mutations alimentaires au Laos#121812HAL (France)
• Étude des mutations microsatellites par des approches basées sur l'utilisation de séquenceurs de première, deuxième et troisième génération#370832HAL (France)
• Colorectal cancer landscape from gut microbiota: Insights into mutations, epigenetic dysregulation, and immune microenvironment alterations#642675Europe PMC
• CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases#994912ClinicalTrials.gov
• Frequency of rare mitochondrial DNA mutations in patients with suspected Leber's hereditary optic neuropathy#1373406Figshare
• Tarceva Italian Lung Optimization tRial#1462484ClinicalTrials.gov
• Study of Muscle Abnormalities in Patients With Specific Genetic Mutations#1463177ClinicalTrials.gov
• A Study of HRS-2329 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications#1007895ClinicalTrials.gov
• The Aim is to Identify Recurrent Genomic Mutations and/or Predisposing Polymorphisms in Patients With Sporadic Cases of Multiple Myeloma#1451252ClinicalTrials.gov
• To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.#916019ClinicalTrials.gov
• Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations#1139354ClinicalTrials.gov
• Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations#1281142ClinicalTrials.gov
• Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations#1293902ClinicalTrials.gov
• A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment#1377758ClinicalTrials.gov
• Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy#825279ClinicalTrials.gov
• A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications#1163140ClinicalTrials.gov
• A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations#1243846ClinicalTrials.gov
• Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations#1280284ClinicalTrials.gov
• Differentiable Repairability & Mutations for Scalable Combinatorial Optimization#1296417arXiv (All)
• Protein language models transfer learning for the prediction of mutational effects and protein disorder#142420HAL (France)
• DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics#1087058ClinicalTrials.gov
• Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations#1497060ClinicalTrials.gov
• TCTEX1D2 mutations underlie Jeune asphyxiating thoracic dystrophy with impaired retrograde intraflagellar transport#954758Koc University Digital Collections
• Cancer mutations in RAD51 and its paralogues.#189949NCBI PubMed Central
• QTX3046 in Patients With KRAS G12D Mutations#837417ClinicalTrials.gov
• Prostate Cancer Screening in Men With Germline BRCA2 Mutations#857559ClinicalTrials.gov